Mafosfamide induced apoptosis in human lymphoblastoid cells: Role of DNA replication, RNA transcription, p53 and Chk1/Chk2

被引：0
|
作者：
Goldstein, M. [1 ]
Roos, W. P. [1 ]
Kaina, B. [1 ]
机构：
[1] Univ Mainz, Dept Toxicol, D-55131 Mainz, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2007年 / 375卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
402
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [11] The Chk2 tumor suppressor is not required for p53 responses in human cancer cells
    Jallepalli, PV
    Lengauer, C
    Vogelstein, B
    Bunz, F
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (23) : 20475 - 20479
  • [12] p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2
    Urist, M
    Tanaka, T
    Poyurovsky, MV
    Prives, C
    GENES & DEVELOPMENT, 2004, 18 (24) : 3041 - 3054
  • [13] Chk2 phosphorylates and stabilizes p53 in response to DNA damage.
    Chehab, N
    Schultz, L
    Malikzay, A
    Appel, M
    Stavridi, E
    Halazonetis, T
    FASEB JOURNAL, 2000, 14 (08): : A1583 - A1583
  • [14] Activation of p53 by DNA-PK and Chk2 upon DNA damage
    Lee, PWK
    RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S24 - S24
  • [15] Chk2 regulates transcription-independent p53-mediated apoptosis in response to DNA damage
    Chen, C
    Shimizu, S
    Tsujimoto, Y
    Motoyama, N
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 333 (02) : 427 - 431
  • [16] Dexamethasone promotes osteoblast apoptosis through the Chk2/p53 signaling pathway
    Zhu, Jie
    Zhao, Tantan
    Zhu, Lunqing
    Yin, Chunhua
    Liu, Yao
    Fang, Jianfeng
    Liang, Hansi
    Zhen, Yunfang
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (12): : 1365 - 1374
  • [17] CHK1 inhibition enhances chemosensitivity of p53 deficient osteosarcoma cells
    Xu, Gufeng
    Wang, Hongmei
    Rainusso, Nino C.
    Flores, Ricardo J.
    Triche, Timothy
    Man, Tsz-Kwong
    Lau, Ching C.
    CANCER RESEARCH, 2011, 71
  • [18] The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites (vol 14, pg 289, 2000)
    Shieh, SY
    Ahn, J
    Tamai, K
    Taya, Y
    Prives, C
    GENES & DEVELOPMENT, 2000, 14 (06) : 750 - 750
  • [19] Irofulven induces replication-dependent CHK2 activation related to p53 status
    Wang, Yutian
    Wiltshire, Timothy
    Senft, Jamie
    Reed, Eddie
    Wang, Weixin
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (04) : 469 - 480
  • [20] DNA damage-induced S phase arrest in human breast cancer depends on Chk1, but G2 arrest can occur independently of Chk1, Chk2 or MAPKAPK2
    Zhang, Wen-Hui
    Poh, Alisa
    Fanous, Andrew A.
    Eastman, Alan
    CELL CYCLE, 2008, 7 (11) : 1668 - 1677
12345